Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$6,113,593
+$817,929 QoQ
Shares Held
24,295
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.86%
of 13F equity value
Holder Rank
#1,192
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. ABBV ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,113,593 | 24,295 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $5,295,664 | 24,349 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,732,585 | 25,089 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $5,973,500 | 25,799 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,809,599 | 25,911 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $5,343,179 | 25,502 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $4,644,011 | 26,134 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $5,209,719 | 26,381 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,648,878 | 27,104 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,210,609 | 28,614 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $4,652,199 | 30,020 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,407,257 | 29,567 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $4,025,597 | 29,879 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,899,830 | 30,745 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $4,861,713 | 30,083 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,257,812 | 31,725 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $4,580,249 | 29,905 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $4,862,489 | 29,995 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $4,069,176 | 30,053 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,381,293 | 31,346 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,266,560 | 29,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,081,564 | 28,475 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,556,170 | 23,856 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,259,924 | 37,218 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,979,996 | 20,167 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,202,506 | 15,783 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||